Szubklinikus hypothyreosis és a cardiovascularis betegség kockázata. Mire utalnak az epidemiológiai vizsgálatok?

Translated title of the contribution: Subclinical hypothyroidism and the risk for cardiovascular diseases. Are epidemiological studies giving the right answers?

János Földes, G. Winkler

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There is ongoing debate whether subclinical hypothyroidism may exert deleterious effects on the cardiovascular system with the consequences of increased morbidity and mortality. To elucidate this problem many epidemiological studies have been performed, however, these studies have not given an unambiguous answer so far. Many confounding elements are influencing the evaluation of these investigations which must be taken into consideration. Authors argue for the use of age specific reference limits for TSH (especially in older age, where TSH level is often shifted to a higher level) to avoid significant misclassification of patients with abnormal TSH who may or may not have thyroid dysfunction. Furthermore, recent studies have shown that subclinical hypothyroidism is associated with increased ischemic heart disease risk, mainly in individuals under the age of 65 years. In the future, well designed prospective randomized studies with age stratified groups and vascular events as the primary endpoint are required and it is anticipated that these studies will give the proper answer whether early substitution therapy with thyroxin will be able to reverse the ischemic heart disease risk in affected patients.

Original languageHungarian
Pages (from-to)1488-1494
Number of pages7
JournalOrvosi Hetilap
Volume151
Issue number37
DOIs
Publication statusPublished - Sep 1 2010

Fingerprint

Hypothyroidism
Myocardial Ischemia
Epidemiologic Studies
Cardiovascular Diseases
Cardiovascular System
Secondary Prevention
Thyroxine
Blood Vessels
Thyroid Gland
Age Groups
Prospective Studies
Morbidity
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Szubklinikus hypothyreosis és a cardiovascularis betegség kockázata. Mire utalnak az epidemiológiai vizsgálatok? / Földes, János; Winkler, G.

In: Orvosi Hetilap, Vol. 151, No. 37, 01.09.2010, p. 1488-1494.

Research output: Contribution to journalArticle

@article{202ad169540f4b44b206fea819f57f08,
title = "Szubklinikus hypothyreosis {\'e}s a cardiovascularis betegs{\'e}g kock{\'a}zata. Mire utalnak az epidemiol{\'o}giai vizsg{\'a}latok?",
abstract = "There is ongoing debate whether subclinical hypothyroidism may exert deleterious effects on the cardiovascular system with the consequences of increased morbidity and mortality. To elucidate this problem many epidemiological studies have been performed, however, these studies have not given an unambiguous answer so far. Many confounding elements are influencing the evaluation of these investigations which must be taken into consideration. Authors argue for the use of age specific reference limits for TSH (especially in older age, where TSH level is often shifted to a higher level) to avoid significant misclassification of patients with abnormal TSH who may or may not have thyroid dysfunction. Furthermore, recent studies have shown that subclinical hypothyroidism is associated with increased ischemic heart disease risk, mainly in individuals under the age of 65 years. In the future, well designed prospective randomized studies with age stratified groups and vascular events as the primary endpoint are required and it is anticipated that these studies will give the proper answer whether early substitution therapy with thyroxin will be able to reverse the ischemic heart disease risk in affected patients.",
keywords = "cardiovascular risk, subclinical hypothyroidism",
author = "J{\'a}nos F{\"o}ldes and G. Winkler",
year = "2010",
month = "9",
day = "1",
doi = "10.1556/OH.2010.28955",
language = "Hungarian",
volume = "151",
pages = "1488--1494",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "37",

}

TY - JOUR

T1 - Szubklinikus hypothyreosis és a cardiovascularis betegség kockázata. Mire utalnak az epidemiológiai vizsgálatok?

AU - Földes, János

AU - Winkler, G.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - There is ongoing debate whether subclinical hypothyroidism may exert deleterious effects on the cardiovascular system with the consequences of increased morbidity and mortality. To elucidate this problem many epidemiological studies have been performed, however, these studies have not given an unambiguous answer so far. Many confounding elements are influencing the evaluation of these investigations which must be taken into consideration. Authors argue for the use of age specific reference limits for TSH (especially in older age, where TSH level is often shifted to a higher level) to avoid significant misclassification of patients with abnormal TSH who may or may not have thyroid dysfunction. Furthermore, recent studies have shown that subclinical hypothyroidism is associated with increased ischemic heart disease risk, mainly in individuals under the age of 65 years. In the future, well designed prospective randomized studies with age stratified groups and vascular events as the primary endpoint are required and it is anticipated that these studies will give the proper answer whether early substitution therapy with thyroxin will be able to reverse the ischemic heart disease risk in affected patients.

AB - There is ongoing debate whether subclinical hypothyroidism may exert deleterious effects on the cardiovascular system with the consequences of increased morbidity and mortality. To elucidate this problem many epidemiological studies have been performed, however, these studies have not given an unambiguous answer so far. Many confounding elements are influencing the evaluation of these investigations which must be taken into consideration. Authors argue for the use of age specific reference limits for TSH (especially in older age, where TSH level is often shifted to a higher level) to avoid significant misclassification of patients with abnormal TSH who may or may not have thyroid dysfunction. Furthermore, recent studies have shown that subclinical hypothyroidism is associated with increased ischemic heart disease risk, mainly in individuals under the age of 65 years. In the future, well designed prospective randomized studies with age stratified groups and vascular events as the primary endpoint are required and it is anticipated that these studies will give the proper answer whether early substitution therapy with thyroxin will be able to reverse the ischemic heart disease risk in affected patients.

KW - cardiovascular risk

KW - subclinical hypothyroidism

UR - http://www.scopus.com/inward/record.url?scp=77956303743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956303743&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28955

DO - 10.1556/OH.2010.28955

M3 - Article

VL - 151

SP - 1488

EP - 1494

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 37

ER -